Development of NIC5-15 in the Treatment of Alzheimer's Disease

NCT00470418 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

FED

Sponsor class

Conditions

Alzheimer Disease
Dementia

Interventions

DRUG: NIC5-15
DRUG: Placebo

Sponsor

VA Office of Research and Development

Collaborators

[object Object]
[object Object]